Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,606.49
(
-0.27%
)
US TECH 100
23,764.40
(
-0.13%
)
Dow Jones
46,021.43
(
-0.44%
)
Brent Oil
103.99
(
-0.42%
)
Bitcoin
70,663.00
(
1.09%
)
News Focus
News Focus
Post# of 257262
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122802
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: zipjet post# 130426

Monday, 11/07/2011 11:16:30 AM

Monday, November 07, 2011 11:16:30 AM

Post# of 257262

They [SNY] gain little other than a foothold for the AG to use when other generics reach market.

SNY gained something else from the AG launch: a defense other than price-cutting to NVS’ market-share gains in the hospital segment, which is for SNY to gain share in the retail segment. Without an AG, SNY couldn’t have done that.

I think we’re on the same wavelength here.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now